hai Congenital Heart Disease Conferences | Meetings | Events | Symposiums | ConferenceSeries

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Recommended Conferences for Congenital Heart Disease

Congenital Heart Disease


As per available reports about 33 Conference Proceedings and 21Relevant Journals are published by OMICS International relevant to Congenital Heart Disease.

Congenital Heart Disease is a general term for a range of birth defects that affect the normal workings of the heart. The term congenital means the condition is present at birth. Congenital heart disease is one of the most common types of birth defect, affecting up to 9 in every 1,000 babies born in the UK. In most cases, no obvious cause of congenital heart disease is identified. However, there are some things known to increase the risk of the condition, including: Down’s syndrome, Rubella, Diabetes type2.

OMICS International organises 1000+ Global Events every Year in Conference series, on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 700+ open access journals  which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.

Scope & Importance

The symptoms for congenital heart disease are rapid heartbeat, rapid breathing, excessive sweating, extreme tiredness, a blue tingle to the skin(cyanosis), tiredness and rapid breathing when a baby is feeding, etc… there are many types of congenital heart disease. Some of them are Septal defects, Coarctation of the aorta, pulmonary valve stenosis, transposition of the great arteries, etc… The treatment for congenital heart disease usually depends on the defect you or your child has.Mild defects, such as holes in the heart, often don't need to be treated, as they may improve on their own and may not cause any further problems.If the defect is significant and is causing problems, surgery is usually required. Modern Surgical techniques can often restore most or all of the heart's normal function, and nowadays about 80% of children with congenital heart disease will survive into adulthood. However, people with congenital heart disease often do need treatment over their life and therefore require specialist review during childhood and adulthood. This is because people with complex heart problems can develop further problems with their heart rhythm or valves over time.

Sometimes CHD improves without treatment. Other defects are so small that they do not require any treatment. Most of the time CHD is serious and requires Surgical and/or medications. Medications include diuretics, which aid the body in eliminating water, salts, and digoxin for strengthening the contraction of the heart. This slows the heartbeat and removes some fluid from tissues. Some defects require surgical procedures to restore circulation back to normal and in some cases, multiple surgeries are needed. Interventional Cardiology now offers patients minimally invasive alternatives to surgery for some patients.

The Melody Transcatheter Pulmonary Valve (TPV), approved in Europe in 2006 and in the U.S. in 2010 under a Humanitarian Device Exemption (HDE), is designed to treat congenital heart disease patients with a dysfunctional conduit in their right ventricular outflow tract (RVOT). The RVOT is the connection between the heart and Lung; once blood reaches the lungs, it is enriched with oxygen before being pumped to the rest of the body. Transcatheter pulmonary valve technology provides a less-invasive means to extend the life of a failed RVOT conduit and is designed to allow physicians to deliver a replacement pulmonary valve via a catheter through the patient’s blood vessels.Most patients require lifelong specialized cardiac care, first with a pediatric cardiologist and later with an adult congenital cardiologist. There are more than 1.8 million adults living with congenital heart defects.

Market Analysis

Congenital heart defects are serious and common conditions that have significant impact on morbidity, mortality, and healthcare costs in children and adults. ·  The most commonly reported incidence of congenital heart defects in the United States is between 4 and 10 per 1,000, clustering around 8 per 1,000 live births. ·  Continental variations in birth prevalence have been reported, from 6.9 per 1000 births in Europe to 9.3 per 1000 in Asia. ·  An estimated minimum of 32,000 infants are expected to be affected each year in the United States. Of these, an approximate 25%, or 2.4 per 1,000 live births, require invasive treatment in the first year of life. The most common types of defects in children are (at a minimum) ventricular septal defects, 620,000 people; ASD, 235,000 people; valvular pulmonary stenosis, 185,000 people; and patent ductus arteriosus, 173,000 people. The most common lesions seen in adults are ASD and TOF.

List of Best International Conferences :

  1. Case Reports Conference
    March 31-April 02 2016 Valencia, Spain
  2. 2nd Pharmacology & Ethnopharmacology Conference
    May 02-04 2016 Chicago, USA
  3. 5th Family Nursing Conference
    June 13-15 2016 Philadelphia, USA
  4. 8th Cardiologists Conference
    July 18-20 2016 Berlin, Germany
  5. 4th Clinical Pharmacy Conference
    October 31-November 01 2016 Las Vegas, USA
  6. Trauma & Critical Care Conference
    March 07-09 2016 Madrid, Spain
  7. 7th Cardiothoracic Conference
    March 29-30 2016 Atlanta, USA
  8. 4th Radiologists Conference
    March 17-18 2016 London, UK
  9. 4th Paediatrics Conference
    March 29-31 2016 Atlanta, USA
  10. 2nd Clinical Case Reports Conference
    April 18-20 2016 Dubai, UAE
  11. 3rd Medical Case Reports Conference
    May 12-14 2016 San Francisco, USA
  12. Nuclear Medicine & Radiation Therapy Conference
    July 14-15 2016 Cologne, Germany
  13. 4th Healthcare Conference
    July 18-20 2016 Brisbane,Australia
  14. Integrative Medicine Conference
    August 11-13 2016 Las Vegas, USA
  15. 6th Nursing & Healthcare Conference
    August 15-17 2016 London, UK
  16. Interventional Cardiology Conference
    September 12-14 2016 Berlin,Germany
  17. 2nd Pediatric Cardiology Conference
    September 22-24 2016 Las Vegas, USA
  18. European Cardiology Congress
    October 24-26 2016 Valencia, Spain
  19. 6th Clinical & Experimental Cardiology Conference
    November 30-December 02 2015 San Antonio, USA
  20. Mayo Clinic Cardiology Update at South Beach: A Focus on Prevention
  21. Arrhythmias & the Heart: A Cardiovascular Update
  22. Hawaii Heart
  23. Cardiovascular Conference at Snowbird
  24. Saudi Heart Association Annual Meeting
  25. International Stroke Conference 2016
  26. Congestive Heart Summat Workshop

Relevant Societies ans Associations

  • World Heart Failure Society
  • American Heart Association
  • Canadian Cardiovascular Society Heart Failure
  • Heart Rhythm Society
  • Association of Women Surgeons
  • Atlanta Heart Associates Pc
  • Heart Failure Society of America
  • Society of Invasive Cardiovascular Professionals
  • American Association of Heart Failure Nurses
  • Association of American Medical Colleges
  • American Medical Association
  • American Society for Artificial Internal Organs
  • American Society of Extra-Corporeal Technology
  • American Society of Transplant Surgeons
  • American Thoracic Society
  • Association for Academic Surgery
  • Canadian Association of Thoracic Surgeons
  • Congenital Heart Surgeons' Society
  • CTSNet
  • Federation of State Medical Boards of the United States
  • General Thoracic Surgery Club
  • Heart Failure Society of America
  • Heart Valve Society of America
  • Perfusion Program Directors' Council
  • Philippine Heart Association

Companies:

  • AUM Cardiovascular
  • CircuLite
  • HearFlow
  • CardioKinetix
  • CardiaLen
  • Cerevast Therapeutics
  • Paragon Medical
  • Procyrion
  • Apaxis Medical
  • Paragon Medical
  • Biotronik
  • Angel Medical Systems
  • Topera Medical
  • Lombard Medical Technologies Plc
  • AtriCure, Inc.
  • Sorin S.p.A.
  • SurModics, Inc.
  • Cook Medical Incorporated
  • Genzyme Corporation
  • GE Healthcare
  • Abiomed, Inc.
  • Osiris Therapeutics, Inc.
  • Boston Scientific Corporation
  • CryoLife, Inc.
  • Philips Healthcare
  • Mesoblast the regenerative medicine company

This page will be updated regularly.

This page was last updated on November 5, 2024

Conference Series Destinations